Your browser doesn't support javascript.
loading
Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas.
Traoré, Abdouramane; Guindo, Merepen A; Konaté, Drissa; Traoré, Bourama; Diakité, Seidina A; Kanté, Salimata; Dembélé, Assitan; Cissé, Abdourhamane; Incandela, Nathan C; Kodio, Mamoudou; Coulibaly, Yaya I; Faye, Ousmane; Kajava, Andrey V; Pratesi, Federico; Migliorini, Paola; Papini, Anna Maria; Pacini, Lorenzo; Rovero, Paolo; Errante, Fosca; Diakité, Mahamadou; Arevalo-Herrera, Myriam; Herrera, Socrates; Corradin, Giampietro; Balam, Saidou.
Affiliation
  • Traoré A; Immunogenetic Laboratory and Parasitology, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Guindo MA; Immunogenetic Laboratory and Parasitology, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Konaté D; Immunogenetic Laboratory and Parasitology, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Traoré B; Department of Ministry of Health and Social Development, Hopital de Dermatologie de Bamako (HDB), Bamako, Mali.
  • Diakité SA; Immunogenetic Laboratory and Parasitology, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Kanté S; Immunogenetic Laboratory and Parasitology, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Dembélé A; Immunogenetic Laboratory and Parasitology, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Cissé A; Immunogenetic Laboratory and Parasitology, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Incandela NC; Center for Polymers and Organic Solids, Department of Chemistry and Biochemistry, University of California Santa Barbara, Santa Barbara, CA, United States.
  • Kodio M; Department of Ministry of Health and Social Development, Hopital de Dermatologie de Bamako (HDB), Bamako, Mali.
  • Coulibaly YI; Department of Ministry of Health and Social Development, Hopital de Dermatologie de Bamako (HDB), Bamako, Mali.
  • Faye O; Department of Ministry of Health and Social Development, Hopital de Dermatologie de Bamako (HDB), Bamako, Mali.
  • Kajava AV; Montpellier Cell Biology Research Center (CRBM), University of Montpellier, CNRS, Montpellier, France.
  • Pratesi F; Immuno-Allergology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Migliorini P; Immuno-Allergology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Papini AM; Interdepartmental Research Unit of Peptide and Protein Chemistry and Biology, Department of Chemistry "Ugo Schiff", University of Florence, Florence, Italy.
  • Pacini L; Interdepartmental Research Unit of Peptide and Protein Chemistry and Biology, Department of Chemistry "Ugo Schiff", University of Florence, Florence, Italy.
  • Rovero P; Interdepartmental Research Unit of Peptide and Protein Chemistry and Biology, Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmaceutical Sciences and Nutraceutics, University of Florence, Florence, Italy.
  • Errante F; Interdepartmental Research Unit of Peptide and Protein Chemistry and Biology, Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmaceutical Sciences and Nutraceutics, University of Florence, Florence, Italy.
  • Diakité M; Immunogenetic Laboratory and Parasitology, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Arevalo-Herrera M; Department of Immunology, Malaria Vaccine and Drug Development Center, Cali, Colombia.
  • Herrera S; Department of Immunology, Caucaseco Scientific Research Center, Cali, Colombia.
  • Corradin G; Department of Immunology, Caucaseco Scientific Research Center, Cali, Colombia.
  • Balam S; Department of Immunology, Malaria Vaccine and Drug Development Center, Cali, Colombia.
Front Immunol ; 13: 856033, 2022.
Article de En | MEDLINE | ID: mdl-35585976
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 / Paludisme Limites: Humans Pays/Région comme sujet: Africa Langue: En Journal: Front Immunol Année: 2022 Type de document: Article Pays d'affiliation: Mali Pays de publication: Suisse
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 / Paludisme Limites: Humans Pays/Région comme sujet: Africa Langue: En Journal: Front Immunol Année: 2022 Type de document: Article Pays d'affiliation: Mali Pays de publication: Suisse